作者
Huanxian Liu,Hongru Zhao,Kaiming Liu,Zhihua Jia,Ming Dong,Yingying Cheng,Yudan Lv,Kang Qu,Wei Gui,Jianjun Chen,Dan Zhang,Zhiliang Fan,Xiaosu Yang,Dongmei Hu,Hongyan Xie,Mingxin Li,Bing Wen,Sufen Chen,Xu Peng,Qingqing Rong,Qiu He,Zhanxiu Ren,Fanhong Yan,Heling Zhao,Min Chen,Tingmin Yu,Hongli Qu,Xingkai An,Huailian Guo,Xinhua Zhang,Xiaoping Pan,Xiaojuan Wang,Shi Qiu,Lvming Zhang,Hongling Zhao,Xin Pan,Qi Wan,Lanyun Yan,Jing Liu,Zhe Yu,Mingjie Zhang,Ye Ran,Xun Han,Zhao Dong,Shengyuan Yu
摘要
Medication-overuse headache (MOH) is a secondary chronic headache disorder that occurs in individuals with a pre-existing primary headache disorder, particularly migraine disorder. Obesity is often combined with chronic daily headaches and is considered a risk factor for the transformation of episodic headaches into chronic headaches. However, the association between obesity and MOH among individuals with migraine has rarely been studied. The present study explored the association between body mass index (BMI) and MOH in people living with migraine.